期刊文献+

蛋白酶体抑制剂诱导卵巢癌SKOV3细胞凋亡中伴随caspase依赖的BAG3剪切 被引量:6

Caspase-dependent cleavage of BAG3 in proteasome inhibitors-induced apoptosis in SKOV3 ovarian cancer cells
下载PDF
导出
摘要 目的:探讨Bcl-2相关抗凋亡基因3(Bcl-2-associated athanogene 2,BAG3)在蛋白酶体抑制剂诱导卵巢癌SKOV3细胞凋亡中的作用。方法:选取人卵巢癌细胞系SKOV3,分别设培养液处理空白对照组、蛋白酶体抑制剂MG132处理组和MG132+Z-VAD联合处理组,按不同时段处理细胞。实时定量RT-PCR法检测各组细胞BAG3 mRNA表达及MG132诱导其表达时效性,Western blot蛋白印迹法检测各组细胞BAG3蛋白表达,流式细胞仪(FCM)检测细胞凋亡。结果:与空白对照组相比,在MG132诱导作用下,SKOV3细胞中BAG3 mRNA表达增加(P<0.01),并随作用时间呈现时效性。发现40kDa BAG3分裂产物,其细胞凋亡率亦随之增加。结论:蛋白酶体抑制剂可诱导上调卵巢癌细胞中BAG3基因表达,BAG3蛋白裂解导致细胞凋亡增加,这一效应可能依赖caspase介导完成。 Objective:To investigate the role of BAG3 in proteasome inhibitor mediated apoptosis in ovarian cancer cells. Methods: SKOV3 cell was cultured and treated with vehicle, MG132, pancaspase inhibitor Z - VAD or combination of Z -VAD and MG132. BAG3 mRNA and protein levels were analyzed by using qPCR and Western blot,respectively. Flow cytometry (FCM) was used to determine the apoptotic rate of cells. Results: Compared with the blank group,BAG3 mRNA expression in the ceils was increased by MG132 in a time -dependence manner (P 〈0. 01 ) ,and simultaneously,cleavage product of BAG3 could be induced by MG132, accompanied with increasing apoptosis rate. Conclusion:Proteasome inhibitor MG132 induces the expression of BAG3 in SKOV3 cells. In proteasome inhibitor treated ceils, BAG3 is cleaved in a caspase- dependent manner.
作者 穆庆 李百鸥
出处 《现代肿瘤医学》 CAS 2013年第5期991-994,共4页 Journal of Modern Oncology
关键词 Bcl-2相关抗凋亡基因3 BCL-2 蛋白酶体抑制剂 caspase 卵巢癌 SKOV3 BAG3 Bcl - 2 proteasome inhibitors caspase ovarian cancer SKOV3
  • 相关文献

参考文献11

  • 1McCollum AK, Casagrande G, Kohn EC. Cauitinthmiddle ; therole of BAG3 in diseases [J]. Biochem J,2009,425( 1〉:1 -3.
  • 2Wanig HQ, Liu BQ,Gao YY’et al. Inhibition of the JNK signalingpathway enhances proteasome inhibitor - induced apoptosis of kid-ney cancer cells by suppression of BAG3 expression[ J]. Br J Phar-macol ,2009,158 (5)=1405-1412.
  • 3Fontanella B’Birolo L,Infusini G, et al. Hie co -cherone BAG3interacts with the cyt<.olic chaperonin CCT : new hints for actinfolding [ J]. Int J Biochem Cell Biol,2010,42(5) :641 -650.
  • 4Iwasaki M,Homma S,Hishiya A,et al. BAG3 regulates motility andadhesion of epithelial cancer cells [ J]. Cancer Res, 2007 , 67(21):10252-10259.
  • 5Chiappetta G, Ammirante My Basile A,et al. The anti - apoptoticprotein BAG3 is expressed in thyroid carcinomas and modulates ap-optosis mediated by tumor necrosis factor related apoptosis inducingligand[ J]. J Clin Endocrinol Metab,2007,92(3) :1159 -1163.
  • 6Peters JM,Franke WW, Kleinschmidt JA. Distinct 19S and 20Ssubcomplexes of the 26S proteasome and their distribution in thenucleus and the cytoplasm[ J] . J Biol Chem, 1994,269 (10) :7709-7718.
  • 7高雁艳,刘宝琴,牛小芳,庄颖,王华芹.胰腺癌细胞凋亡伴随胱天蛋白酶依赖性BAG3蛋白剪切的研究[J].中华肿瘤防治杂志,2011,18(2):81-84. 被引量:6
  • 8牟科,付翌秋,徐萍.蛋白酶体抑制剂的研究进展[J].国际药学研究杂志,2009,36(5):348-354. 被引量:4
  • 9Adams J. TTie devopment of proteasome inhibitors as anticancerdrugs [J]. Cancer Cell,2004,5(5) :417 -421.
  • 10张海燕,高雁艳,刘宝琴,邓娓娓,刘国良,王华芹.Bcl-2相关抗凋亡基因3对蛋白酶体抑制剂抗肿瘤作用影响的观察[J].中华肿瘤防治杂志,2009,16(21):1621-1624. 被引量:3

二级参考文献81

  • 1刘桐宇,叶建新.蛋白酶体抑制剂治疗多药耐药肿瘤机制的研究进展[J].中华肿瘤防治杂志,2007,14(15):1187-1190. 被引量:6
  • 2Tanaka K, Yoshimura T, Kumatori A, et al. Proteasomes ( multiprotease complexes)as 20S ring-shaped particles in a variety of eukaryofic cells [ J ]. J Biol Chem, 1988, 263 ( 31 ) : 16209 - 16217.
  • 3Kisselev AF, Goldberg AL. Proteasome inhibitors:from research tools to drug candidates[J]. Chem Biol, 2001, 8 (8) :739 - 758.
  • 4Yang YL, Kitagaki J, Wang HH, et al. Targeting the ubiquitinproteasome system for cancer therapy [ J ]. Cancer Sci, 2009, 100 (1) :24 -28.
  • 5Groll M, Huber R, Moroder L. The persisting challenge of selective and specific proteasome inhibition[ J ]. J Pept Sci, 2009, 15 (2) :58 -66.
  • 6Meiners S, Ludwig A, Stangl V, et al. Proteasome inhibitors: poisons and remedies [ J ]. Med Res Rev, 2008, 28 (2) :309 - 327.
  • 7Koegl M, Hoppe T, Schlenker S, et al. A novel ubiquitination factor, E4, is involved in uhiubiquitin chain assembly [ J ]. Cell, 1999, 96(5) :635 -644.
  • 8Karin M, Cao Y, Greten FR, et al. NF-KB in cancer:from innocent bystander to major culprit[ J]. Nat Rev Cancer, 2002, 2 (4) :301 -310.
  • 9King RW, Deshaies RJ, Peters JM, et al. How proteolysis drives the cell cycle [ J ]. Science, 1996, 274 ( 5293 ) : 1652 - 1659.
  • 10Schubert U, Anton LC, Gibbs J, et al. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes [ J ]. Nature, 2000, 404(6779) :770 -774.

共引文献9

同被引文献51

  • 1傅晶,张东明,陈若芸.远志属植物的皂苷类成分及其药理作用研究进展[J].中草药,2006,37(1):144-146. 被引量:66
  • 2倪晓光,赵平.泛素-蛋白酶体途径的组成和功能[J].生理科学进展,2006,37(3):255-258. 被引量:43
  • 3桑德春,纪树荣,张缨,金萍.Fugl-Meyer量表在社区脑卒中康复疗效评定中的应用[J].中国康复医学杂志,2007,22(3):264-265. 被引量:185
  • 4Tanaka K,Yoshimura T,Kumatori A,et al. Proteasomes (muhiprotease complexes) as 20S ring-shaped particles in avariety of eukaryotic cells[J]. J Biol Chem, 1988,263(31): 16209-16217.
  • 5Almond JB, Cohen GM. The proteasome:a novel target for cancer chemotherapy[J]. Leukemia,2002,16(4):433-444.
  • 6Doong H,Price J,Kim YS,et al. CAIR-1/BAG-3 forms an EGF-regulated ternary complex with phospholipase C- gamma and Hsp70/ Hsc70[J]. Oncogene,2000,19(38) : 4385-4395.
  • 7Antoku K,Maser RS,Seully WJ Jr,et al. Isolation of Bcl-2 binding proteins that exhibit homology with BAG21 and suppressor of death domains protein [J]. Biochem Biophys Res Commun,2001,286 (5):1003-1010.
  • 8McCollum AK,Casagrande G,Kohn EC. Caughtinthemid- dle:the role of Bag3 in diseases[J]. Biochem J, 2009,425 (1): 1-3.
  • 9Wang HQ, Liu BQ,Gao YY,et al. Inhibition of the JNK signaling pathway enhances proteasome inhibitor-induced apoptosis of kidney cancer cells by suppression of BAG3 expression [J]. Br J Pharmaeol,2009,158 (5):1405-1412.
  • 10Chiappetta G, Ammirante M, Basile A, et al. The anti-apop- totic protein BAG3 is expressed in thyroid carcinomas and modulates apoptosis mediated by tumor necrosis factor re- lated apoptosis inducing ligand[J]. J Clin Endocrinol Metab, 2007,92(3) : 1159-1163.

引证文献6

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部